Human Health raises €4.7M to grow its patient-first Precision Health platform

Across the EU, over one in three adults (35%) live with a long-term health condition, and longer waiting times in many countries force patients to manage care across different providers using disconnected tools.

Human Health aims to fix this by creating patient-centred solutions. Its Precision Health platform uses AI and patient-reported data to track health, find patterns, and generate useful insights. The goal is to make precision healthcare accessible to everyone, not just hospitals and specialists.

Read Also - Earlybird Health names two new partners to strengthen its focus on biotech and data-driven healthcare

Founded by former Canva product leaders Kate Lambridis and Georgia Vidler, the platform lets users record their medical history, track treatments, and create clinician-ready reports. With permission, users can also share anonymised data for research. The AI analyses connections between mind, body, and lifestyle, helping users manage areas such as mental health, gut health, pain, sleep, women’s health, and autoimmune conditions.

The new funding will be used to build advanced features, cover more health conditions, and expand data-sharing for research.

Human Health also plans to grow its B2B platform, Human Evidence, which allows life sciences partners to collect large-scale, real-world patient data to support research and innovation.

About Human Health

A “human health company” is a broad term for any business focused on improving people’s health. This can include companies that provide medical services (like clinics, dentists, or specialists), develop pharmaceuticals, create medical devices, build digital health platforms, or offer holistic and functional health solutions. Many companies use the name “Human Health,” but their exact work can vary some focus on clinical care, others on life sciences research, and some on patient engagement and technology.